Mg OSTEOCRETE Post-Treatment Outcomes

Description

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Conditions

Cancer of Bone, Trauma, Aseptic Loosening of Orthopaedic Hardware

Study Overview

Study Details

Study overview

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Clinical and Radiographic Outcomes of Patients Treated With Mg OSTEOCRETE

Mg OSTEOCRETE Post-Treatment Outcomes

Condition
Cancer of Bone
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age and older on the day of surgery
  • * has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product
  • * Mg OSTEOCRETE is indicated for one of the following reasons:
  • 1. as a bone void filler following bone tumor resection, or;
  • 2. as an augment for defects causing aseptic loosening of orthopaedic implants, or;
  • 3. to help substitute bone for trauma-related conditions
  • * any contraindication as per Instructions for Use for Mg OSTEOCRETE

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Santiago Lozano-Calderon,

Santiago A Lozano-Calderon, MD, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2026-06